ELISA found that the levels of inflammatory factors IL-1β, IL-6 and IL-8 decreased significantly in the serum of miR-181a-5p agomir-treated DVT mice (Fig. 4I-K). This evidence concerns the gene IL1B and deep vein thrombosis.